The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon


Work +617 570 1000
Fax +617 523 1231

Mitchell Bloom

Work +1 617 570 1055


Partner Chair, Life Sciences Practice


Mitchell Bloom is national Chair of Goodwin Procter’s Life Sciences Practice. Mr. Bloom specializes in representing public and private life science companies, as well as venture capital firms and investment banks focused on the life sciences sector, including matters involving biotechnology, medical devices, diagnostics and healthcare information technology.


J.D., 1989 Boston College Law School B.S., 1986 Suffolk University (cum laude)

United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

Goodwin 's Boston-based practice co-head Mitchell Bloom, who specializes in venture capital firms and investment banks focused on life sciences, recently assisted Ablynx with its €3.9bn agreement to be acquired by Sanofi, and advised California-based biopharmaceutical company Eidos on its $106m initial public offering. Co-head Kingsley Taft (also based in Boston) advised long-standing client Moderna on a $500m equity financing round. Surface Oncology and Zagfen are other notable clients. New-York-based Elizabeth Holland is well versed in Hatch-Waxman litigation, while Washington DC’s Julie Tibbets, who joined from Alston & Bird LLP in February 2018, focuses on FDA regulatory work. Other key arrivals in 2018 include New York-based Jonathan Schur and Kristopher Brown from Dechert LLP, San Francisco’s IP litigator Darryl Woo from Vinson & Elkins LLP and Silicon Valley’s Shane Albright from DLA Piper LLP (US). Boston’s Chad Davis moved to  Dechert LLP.

[back to top]

United States: M&A/corporate and commercial

Venture capital and emerging companies

Within: Venture capital and emerging companies

With offices in Boston, Washington DC, New York, Los Angeles and the Bay Area, Goodwin has a wide-ranging, bicoastal practice, which has an excellent reputation for its strength in the life sciences sector; tech is a supplementary area of expertise. The team represented online pharmacy PillPack in its high-profile acquisition by Amazon, and assisted Kensho Technologies with its $550m sale to S&P Global. It also advised Slack Technologies on its $427m Series H financing. Mitchell Bloom and Kingsley Taft, both based in Boston, share leadership of the life sciences team, while John Egan, Anthony McCusker in Silicon Valley, and Kenneth Gordon lead the technology practice. Boston-based Bill Schnoor, who advises robotics company Superpedestrian, is another key contact. Jonathan Axelrad has retired.

[back to top]

Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to